FDA Approves First Autonomous AI Software to Detect Eye Disease
The FDA grants approval to IDx-DR, the first artificial intelligence program that diagnoses diabetic retinopathy without requiring a specialist's input. The technology allows general healthcare providers to screen patients quickly using a special retinal camera.
The Food and Drug Administration approves the first artificial intelligence software that diagnoses a medical condition without the direct involvement of a clinician. The program, known as IDx-DR, analyzes images of the retina to detect diabetic retinopathy, a common eye disease affecting individuals with diabetes.
Health care providers need only minimal training to operate the special camera required to capture the retinal images. The algorithm then processes these pictures independently to determine if the patient shows signs of the disease, recommending a visit to an eye specialist only if the software detects a problem.
This computer program represents a major shift in medical diagnostics by potentially saving patients time and money. By allowing primary care physicians and other non-specialists to screen for the disease, the technology reduces the need for unnecessary and expensive trips to specialized eye doctors.